Drugs and the renin-angiotensin system in covid-19

被引：69

作者：

Aronson, Jeffrey K. ^{[1
]}

Ferner, Robin E. ^{[2
]}

机构：

[1] Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England

[2] Univ Birmingham, Inst Clin Sci, Birmingham, W Midlands, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2020年 / 369卷

关键词：

D O I：

10.1136/bmj.m1313

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页数：2

共 11 条

[1]

Aronson J.K., ANGIOTENSIN CONVERTI

[2]

Aronson JK, 2020, BOST STUD PHILOS HIS, V338, P3, DOI 10.1007/978-3-030-29179-2_1

[3]

Aronson JK, COVID 19 TRIALS REGI

[4]

BOZKURT B, HFSA ACC AHA STATEME

[5]

European Society of Cardiology, 2020, Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers.

[6]

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 [J].

Ferrario, CM ;

Jessup, J ;

Chappell, MC ;

Averill, DB ;

Brosnihan, KB ;

Tallant, EA ;

Diz, DI ;

Gallagher, PE .

CIRCULATION, 2005, 111 (20) :2605-2610

[7]

Heneghan C., 2020, NSAIDS ACUTE RESP IN

[8]

Hoffmann M, 2020, CELL, DOI [10.1016/j.cell.2020.02.052.32142651, DOI 10.1016/J.CELL.2020.02.052.32142651]

[9]

Matsuyama S, 2020, P NATL ACAD SCI USA, DOI 10.1073/pnas.200258911732165541

[10]

AT2 Receptor and Tissue Injury: Therapeutic Implications [J].

Namsolleck, Pawel ;

Recarti, Chiara ;

Foulquier, Sebastien ;

Steckelings, Ulrike Muscha ;

Unger, Thomas .

CURRENT HYPERTENSION REPORTS, 2014, 16 (02)

← 1 2 →